Home › Compare › BMCS vs ADC

BMCS vs ADC: Dividend Comparison 2026

BMCS yields 181818.18% · ADC yields 4.13%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BMCS wins by $1.8951031795759825e+29M in total portfolio value
10 years
BMCS
BMCS
● Live price
181818.18%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.8951031795759825e+29M
Annual income
$189,305,502,041,192,720,000,000,000,000,000,000.00
Full BMCS calculator →
ADC
Agree Realty Corporation
● Live price
4.13%
Share price
$74.97
Annual div
$3.10
5Y div CAGR
40.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$178.9K
Annual income
$80,797.29
Full ADC calculator →

Portfolio growth — BMCS vs ADC

📍 BMCS pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBMCSADC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BMCS + ADC cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
BMCS pays
ADC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BMCS
Annual income on $10K today (after 15% tax)
$15,454,545.45/yr
After 10yr DRIP, annual income (after tax)
$160,909,676,735,013,800,000,000,000,000,000,000.00/yr
ADC
Annual income on $10K today (after 15% tax)
$351.36/yr
After 10yr DRIP, annual income (after tax)
$68,677.70/yr
At 15% tax rate, BMCS beats the other by $160,909,676,735,013,800,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BMCS + ADC for your $10,000?

BMCS: 50%ADC: 50%
100% ADC50/50100% BMCS
Portfolio after 10yr
$9.475515897879912e+28M
Annual income
$94,652,751,020,596,360,000,000,000,000,000,000.00/yr
Blended yield
99.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ADC right now

BMCS
No analyst data
Altman Z
0.3
Piotroski
3/9
ADC
Analyst Ratings
1
Strong
22
Buy
9
Hold
Consensus: Buy
Price Target
$81.06
+8.1% upside vs current
Range: $75.00 — $84.50
Altman Z
1.6
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BMCS buys
0
ADC buys
0
No recent congressional trades found for BMCS or ADC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBMCSADC
Forward yield181818.18% ✓4.13%
Annual dividend / share$2.00$3.10 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%40.4% ✓
Portfolio after 10y$1.8951031795759825e+29M$178.9K ✓
Annual income after 10y$189,305,502,041,192,720,000,000,000,000,000,000.00 ✓$80,797.29
Total dividends collected$1.8949690612486723e+29M$156.7K ✓
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: BMCS vs ADC ($10,000, DRIP)

YearBMCS PortfolioBMCS Income/yrADC PortfolioADC Income/yrGap
1← crossover$18,192,518$18,181,818.18$10,990$580.36+$18.18M → BMCS
2$30,932,835,887$30,913,369,892.64$12,301$860.26+$30932.82M → BMCS
3$49,156,619,660,049$49,123,521,525,649.34$14,104$1,298.62+$49156619.65M → BMCS
4$73,009,768,971,452,110$72,957,171,388,415,860.00$16,691$2,008.16+$73009768971.44M → BMCS
5$101,348,671,691,011,770,000$101,270,551,238,212,300,000.00$20,580$3,205.09+$101348671691011.75M → BMCS
6$131,490,628,941,834,950,000,000$131,382,185,863,125,600,000,000.00$26,754$5,330.02+$131490628941834960.00M → BMCS
7$159,445,709,700,484,420,000,000,000$159,305,014,727,516,640,000,000,000.00$37,196$9,345.14+$159445709700484431872.00M → BMCS
8$180,706,560,655,892,340,000,000,000,000$180,535,953,746,512,850,000,000,000,000.00$56,244$17,523.09+$1.8070656065589233e+23M → BMCS
9$191,416,744,304,199,340,000,000,000,000,000$191,223,388,284,297,560,000,000,000,000,000.00$94,286$35,736.21+$1.9141674430419936e+26M → BMCS
10$189,510,317,957,598,240,000,000,000,000,000,000$189,305,502,041,192,720,000,000,000,000,000,000.00$178,949$80,797.29+$1.8951031795759825e+29M → BMCS

BMCS vs ADC: Complete Analysis 2026

BMCS — Stock

BioTech Medics, Inc. operates as a medical-based holding company. The company operates medical therapeutic laser centers that treat various pain ailments affecting the muscles, nerves, and bones, as well as arthritis. It also offers SHBAN, an antiseptic hand and body sanitizer. In addition, the company develops and sells nutraceutical products, such as BioBody Balance, a liquid vitamin concentrate; and BioBody Energy Spray, a caffeine and alcohol free natural vitamin energy spray. It offers its nutraceutical products through gross retail sales. The company was incorporated in 1997 and is based in Southlake, Texas with laser pain centers in Texas, California, New Mexico, and Florida.

Full BMCS Calculator →

ADC — REIT

Agree Realty Corporation is a publicly traded real estate investment trust primarily engaged in the acquisition and development of properties net leased to industry-leading retail tenants. As of September 30, 2020, the Company owned and operated a portfolio of 1,027 properties, located in 45 states and containing approximately 21.0 million square feet of gross leasable area. The Company's common stock is listed on the New York Stock Exchange under the symbol ADC.

Full ADC Calculator →
📬

Get this BMCS vs ADC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BMCS vs SCHDBMCS vs JEPIBMCS vs OBMCS vs KOBMCS vs MAINBMCS vs NNNBMCS vs EPRTBMCS vs FCPT

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.